Compare AEIS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEIS | MEDP |
|---|---|---|
| Founded | 1981 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 11.9B |
| IPO Year | 1996 | 2016 |
| Metric | AEIS | MEDP |
|---|---|---|
| Price | $301.00 | $446.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 12 |
| Target Price | $307.73 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 919.2K | 309.6K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | ★ 0.11% | N/A |
| EPS Growth | ★ 168.53 | 20.98 |
| EPS | 1.58 | ★ 4.28 |
| Revenue | ★ $453,095,000.00 | N/A |
| Revenue This Year | $22.53 | $13.19 |
| Revenue Next Year | $13.38 | $7.75 |
| P/E Ratio | $200.87 | ★ $104.64 |
| Revenue Growth | ★ 38.39 | N/A |
| 52 Week Low | $112.72 | $291.28 |
| 52 Week High | $397.44 | $628.92 |
| Indicator | AEIS | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 37.31 | 56.69 |
| Support Level | $292.32 | $447.80 |
| Resistance Level | $355.00 | $477.04 |
| Average True Range (ATR) | 16.72 | 14.05 |
| MACD | -2.51 | 5.18 |
| Stochastic Oscillator | 17.14 | 90.75 |
Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.